Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) FCF Margin (2017 - 2019)

Historic FCF Margin for Iterum Therapeutics (ITRM) over the last 3 years, with Q1 2019 value amounting to 40710.81%.

  • Iterum Therapeutics' FCF Margin fell 346055800.0% to 40710.81% in Q1 2019 from the same period last year, while for Dec 2019 it was 221475.68%, marking a year-over-year decrease of 2125755600.0%. This contributed to the annual value of 808.58% for FY2024, which is 4404100.0% down from last year.
  • Latest data reveals that Iterum Therapeutics reported FCF Margin of 40710.81% as of Q1 2019, which was down 346055800.0% from 10547.28% recorded in Q4 2018.
  • Iterum Therapeutics' FCF Margin's 5-year high stood at 2914.04% during Q4 2017, with a 5-year trough of 40710.81% in Q1 2019.
  • For the 3-year period, Iterum Therapeutics' FCF Margin averaged around 11661.53%, with its median value being 7006.49% (2018).
  • Per our database at Business Quant, Iterum Therapeutics' FCF Margin crashed by -73153800bps in 2018 and then plummeted by -346055800bps in 2019.
  • Quarter analysis of 3 years shows Iterum Therapeutics' FCF Margin stood at 2914.04% in 2017, then tumbled by -262bps to 10547.28% in 2018, then tumbled by -286bps to 40710.81% in 2019.
  • Its FCF Margin stands at 40710.81% for Q1 2019, versus 10547.28% for Q4 2018 and 10831.1% for Q3 2018.